Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000036

Chief Medical Officer sold 17,611 shares at an average $55.12 ($970,636)

  • Chief Medical Officer acquired 17,611 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-19 Exercise or conversion : show line 1 in the form +3,210 $35.16 $112,864 18,697 D
2021-04-19 Sale : show line 2 in the form −3,210 $55.16 $177,055 15,487 D
2021-04-20 Exercise or conversion : show line 3 in the form +12,513 $35.16 $439,957 28,000 D
2021-04-20 Exercise or conversion : show line 4 in the form +1,888 $39.76 $75,067 29,888 D
2021-04-20 Sale : show line 5 in the form −14,401 $55.11 $793,582 15,487 D
Open-market sales · 17,611 sh · avg $55.12 · $970,636

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-04-19 Exercise or conversion : show line 6 in the form Stock option (right to buy) −3,210 12,513 D
2021-04-20 Exercise or conversion : show line 7 in the form Stock option (right to buy) −12,513 0 D
2021-04-20 Exercise or conversion : show line 8 in the form Stock option (right to buy) −1,888 43,332 D
Loading xslF345X03/wf-form4_161903949035322.xml…